Biosimilars Check Up: Part 2

By AmerisourceBergen

Rethink: Biosimilar Adoption in the United States 

While biosimilar manufacturers may seemingly face the same commercialization challenges as any manufacturer (coverage, competition, and patient access), physician confidence is critical, creating an additional layer of challenges – and launch considerations.

In these new survey results you'll learn:
  • How to create confidence in switching to a biosimilar
  • The right mix of education and support services to deploy
  • What commercialization investments can help ensure success

Download Survey Results: Part 2